PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 228 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,103 | -93.8% | 22,647 | -90.2% | 0.00% | -100.0% |
| Q2 2023 | $3,060,091 | -66.4% | 230,082 | -70.7% | 0.00% | -66.7% |
| Q1 2023 | $9,098,105 | +2005.1% | 785,674 | +1387.0% | 0.00% | – |
| Q4 2022 | $432,191 | -7.1% | 52,835 | -34.1% | 0.00% | – |
| Q3 2022 | $465,000 | +165.7% | 80,185 | +102.3% | 0.00% | – |
| Q2 2022 | $175,000 | -80.2% | 39,631 | -59.2% | 0.00% | – |
| Q1 2022 | $885,000 | -56.7% | 97,222 | -2.8% | 0.00% | -100.0% |
| Q4 2021 | $2,046,000 | -26.9% | 99,982 | -8.7% | 0.00% | 0.0% |
| Q3 2021 | $2,799,000 | -48.5% | 109,552 | -29.5% | 0.00% | -50.0% |
| Q2 2021 | $5,431,000 | +87.7% | 155,308 | +78.8% | 0.00% | +100.0% |
| Q1 2021 | $2,894,000 | +34.6% | 86,880 | +4.8% | 0.00% | 0.0% |
| Q4 2020 | $2,150,000 | +476.4% | 82,884 | +119.2% | 0.00% | – |
| Q3 2020 | $373,000 | +213.4% | 37,805 | +9.1% | 0.00% | – |
| Q2 2020 | $119,000 | -73.6% | 34,640 | -76.5% | 0.00% | – |
| Q1 2020 | $451,000 | -92.4% | 147,482 | -87.3% | 0.00% | -100.0% |
| Q4 2019 | $5,967,000 | -27.1% | 1,160,945 | -26.8% | 0.00% | -33.3% |
| Q3 2019 | $8,180,000 | -18.1% | 1,585,152 | -3.9% | 0.00% | -25.0% |
| Q2 2019 | $9,983,000 | -10.8% | 1,650,010 | +6.6% | 0.00% | -20.0% |
| Q1 2019 | $11,188,000 | -21.2% | 1,547,494 | -19.4% | 0.01% | -16.7% |
| Q4 2018 | $14,202,000 | +434.7% | 1,919,173 | +290.9% | 0.01% | +500.0% |
| Q3 2018 | $2,656,000 | +91.5% | 490,927 | +25.6% | 0.00% | 0.0% |
| Q2 2018 | $1,387,000 | +124.1% | 390,816 | +29.5% | 0.00% | – |
| Q1 2018 | $619,000 | +34.3% | 301,726 | +72.8% | 0.00% | – |
| Q4 2017 | $461,000 | -68.1% | 174,614 | -36.6% | 0.00% | -100.0% |
| Q3 2017 | $1,445,000 | +258.6% | 275,301 | +143.1% | 0.00% | – |
| Q2 2017 | $403,000 | -31.2% | 113,235 | -0.2% | 0.00% | – |
| Q1 2017 | $586,000 | -97.4% | 113,501 | -98.1% | 0.00% | -100.0% |
| Q4 2016 | $22,138,000 | +2957.7% | 5,825,792 | +7113.0% | 0.01% | – |
| Q3 2016 | $724,000 | -9.3% | 80,768 | -28.8% | 0.00% | -100.0% |
| Q2 2016 | $798,000 | +1146.9% | 113,398 | +1408.4% | 0.00% | – |
| Q1 2016 | $64,000 | -50.0% | 7,518 | -23.1% | 0.00% | – |
| Q4 2015 | $128,000 | +481.8% | 9,771 | +57.2% | 0.00% | – |
| Q3 2015 | $22,000 | -58.5% | 6,215 | -32.3% | 0.00% | – |
| Q2 2015 | $53,000 | +178.9% | 9,176 | +186.8% | 0.00% | – |
| Q1 2015 | $19,000 | -5.0% | 3,200 | +28.0% | 0.00% | – |
| Q4 2014 | $20,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |